Oleg E Akilov
Overview
Explore the profile of Oleg E Akilov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
995
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Foss F, Kim Y, Prince H, Akilov O, Querfeld C, Seminario-Vidal L, et al.
J Clin Oncol
. 2024 Dec;
JCO2401549.
PMID: 39700456
Purpose: Denileukin diftitox (DD)-cxdl is a fusion protein comprising diphtheria toxin fragments A and B and human interleukin-2. This phase III, multicenter, open-label, single-arm registrational trial evaluated the efficacy and...
2.
Akilov O
J Eur Acad Dermatol Venereol
. 2024 Sep;
38(10):1844-1845.
PMID: 39319952
No abstract available.
3.
Gordon E, Trager M, Kwinta B, Stonesifer C, Lee K, Adeuyan O, et al.
Leuk Lymphoma
. 2024 Jul;
65(12):1883-1890.
PMID: 38975910
There are no established maintenance protocols for cutaneous lymphomas. We aim to determine patient treatments and outcomes during the COVID-19 pandemic in order to uncover the most effective maintenance protocols...
4.
Jiang T, Kruglov O, Akilov O
Blood Adv
. 2024 Mar;
8(10):2384-2397.
PMID: 38489234
Sézary syndrome (SS) is an aggressive leukemic expansion of skin-derived malignant CD4+ T cells. Drug monotherapy often results in disease relapse because of the heterogenous nature of malignant CD4+ T...
5.
Jiang T, Cao S, Kruglov O, Virmani A, Geskin L, Falo Jr L, et al.
J Invest Dermatol
. 2023 Nov;
144(5):1088-1098.
PMID: 38036289
Cutaneous T-cell lymphomas are a heterogeneous group of neoplasms originating in the skin, with mycosis fungoides (MF) and Sézary syndrome (SS) representing the most common variants. The cellular origin of...
6.
Akilov O
Cells
. 2023 Sep;
12(18).
PMID: 37759543
Extracorporeal photopheresis (ECP) is an FDA-approved immunotherapy for cutaneous T-cell lymphoma, which can provide a complete response in some patients. However, it is still being determined who will respond well,...
7.
CD5+ Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Presenting as an Asymptomatic Nodule
Xiao A, Beatty C, Choudhary S, Akilov O
Hematol Rep
. 2023 Sep;
15(3):513-517.
PMID: 37754668
Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT), is a rare and aggressive variant of primary cutaneous lymphoma that typically expresses B cells as well as MUM1/IRF4, BCL2, and...
8.
Han Z, Wu X, Qin H, Yuan Y, Zain J, Smith D, et al.
J Invest Dermatol
. 2023 Mar;
143(8):1569-1578.e5.
PMID: 36863449
Cutaneous T-cell lymphoma (CTCL) is an incurable and cosmetically disfiguring disease associated with microenvironmental signals. We investigated the effects of CD47 and PD-L1 immune checkpoint blockades, as a strategy for...
9.
Xiao A, Akilov O
Cells
. 2022 Nov;
11(22).
PMID: 36429020
The loss of CD47 on aging cells serves as a signal to macrophages to eliminate the target. Therefore, CD47 is a "do-not-eat-me" sign preventing macrophagal phagocytosis via interaction with its...
10.
Xiao A, Miedler J, Akilov O
JAAD Case Rep
. 2022 Nov;
30:38-40.
PMID: 36386059
No abstract available.